Purpose: Valproate is one of the most commonly used anticonvulsive drugs. Despite its significant benefits, the teratogenicity of valproate is a relevant problem in the treatment of women of childbearing age. In addition to major congenital malformations, such as neural tube defects, reduced intelligence and attention after intrauterine valproate exposure are reported. Until now the mechanisms of teratogenicity of VPA are poorly understood and concepts how to reduce valproate teratogenicity are lacking. Methods: In a rat model of valproate teratogenicity we examined hippocampal cell structure in 4 week old animals with a stereological approach. As potential mechanisms of VPA teratogenicity we examined histone acetylation by western blotting and metabolites of the folate metabolism as well as global DNA methylation by tandem mass spectrometry in the brain and liver tissue of newborn pups (p0). Results: We found an increase in the number of neurons in the hippocampal areas CA1/2 (p = 0.018) and CA3 (p = 0.022), as well as a decreased number of astrocytes in CA1/2 (p = 0.004) and CA3 (p = 0.003) after intrauterine VPA exposure, as a possible indication of altered cell differentiation during intrauterine VPA exposure. Valproate exposure was also associated with an increase in 5-methyl-tetrahydrofolate (THF) (p = 0.002) and a decrease in 5-10-methenyl-THF in the brain of newborn pups, as well as a reduced homocysteine plasma level (p < 0.001). The described changes in hippocampal cell numbers and folate metabolism were only significant after high-dose intrauterine VPA exposure indicating a dose-dependent effect. VPA exposure was not associated with changes in histone acetylation or global DNA methylation in brain tissue in newborn pups. Conclusion: This study shows that intrauterine VPA exposure is associated with changes in hippocampal cell numbers in the CA1/2 and CA3 region and in folate metabolism.
Introduction
Valproate (VPA) is used in the treatment of epilepsy and psychiatric diseases worldwide and is one of the most used anticonvulsive drugs. Its considerable benefit is limited by toxicity and teratogenicity. The teratogenicity of VPA is a relevant problem in the treatment of women at childbearing age, and particularly high malformation rates are recorded for dosages of 1500 mg per day or greater. Neural tube, cardiac, facial, skeletal, and other defects are reported [1, 2] . In addition to that, children exposed to VPA in utero, show a significant decrease in measures of intelligence and attention [3] [4] [5] [6] . Therefore, intake of valproate during pregnancy is not recommended, especially in higher dosages. However, some women need to maintain the use of VPA during pregnancy for continued seizure control. Until now systematic data on the mechanisms of teratogenicity of VPA are lacking. Therefore it is unclear how to control or decrease the risk of intrauterine VPA exposure.
Consistent with its broad clinical effectiveness valproate has multiple cellular mechanisms of action which also could be responsible for its teratogenicity. In this study we aimed at investigating three possible mechanisms of VPA teratogenicity: interruption of folate metabolism [7, 8] , and two potential epigenetic changes, DNA hypomethylation [9] , and inhibition of histone deacetylase (HDAC) activity [10, 11] .
It is already established that treatment with valproate is associated with lowered serum folate levels in adult epilepsy patients [12] . Moreover, intrauterine disturbance of folate metabolism is well known to impair brain development and lead to cognitive impairment [13, 14] . In mice, folic acid pretreatment in pregnant mice significantly reduced VPA-induced neural tube defects in their offspring [15] . Therefore, disruption of folate metabolism might be a possible mechanism of valproate teratogenicity [16, 17] .
Folic acid metabolism also plays a critical role in the methylation of DNA [18] . We have recently shown that intrauterine VPA exposure is associated with alterations of two important metabolites of folate metabolism S-adenosyl-methionine (SAM) and its demethylated residue S-adenosyl-homocysteine (SAH) in the liver and brain tissue after intrauterine VPA exposure [8] . The SAM/SAH ratio represents the cellular methylation capacity [19] . In addition to that it is already shown that inhibition of intrauterine folate metabolism is associated with DNA hypomethylation and neural tube defects [20, 21] . We therefore examined global DNA methylation in the brain tissue of pups after intrauterine VPA exposure.
Histones serve as epigenetic regulators of gene expression. Histone deacetylases are enzymes that remove acetyl groups from histones and thus alter their interaction with DNA [22, 23] . In vitro and cell culture experiments have demonstrated that VPA can directly inhibit HDAC activity and cause hyperacetylation of histones [10, 11] , a mechanism probably relevant during intrauterine development.
We recently established a rat model of valproate teratogenicity by chronic delivery of VPA to dams via drinking water, thereby avoiding very high peak VPA doses achieved by repetitive VPA injections, which are related to severe side effects and limit interpretation of VPA teratogenic effects. In this model, we found a reduction of cortical volume induced by high VPA doses, while medium VPA doses induced slight hippocampal volume increases [24] . In the present study, we further investigated volumetric changes and changes in cell numbers by stereological examination of the hippocampus after intrauterine VPA exposure in juvenile animals 4 weeks of age.
Methods
Male and female parental Wistar rats aged 10 weeks (Charles River, Germany) were group-housed (4 per group) in the animal facility of the university hospital. The rat chow used in this study was Altromin Standard Diet, 1330 (Altromin, Soest, Germany). After 10 days of habituation, valproate (Sigma, Darmstadt) was diluted into the drinking water. Valproate metabolism and kinetics differ in humans and rodents with ten times higher metabolic rates in mice and rats [25] . Therefore, to reach a serum level between 50-100 mg/ml at least during the nightly active period without very high peak concentrations, VPA drinking water concentrations of 3.3, and 6.6 mg/ml were used. This results in daily valproate dosages in female pregnant rats of about 500, and 825 mg/kg [24] .
Respective groups are termed MD (medium dose) group and HD (high dose) group in this manuscript. These dosages do not affect physical parameters as weight gain and food intake or behavior [24] . The higher dosage is close to the upper border of drug load applicable without induction of hepatic malfunction in the rat [26] . After seven days, drug application was interrupted, and one male animal was placed into each female group. Male rats were not exposed to VPA. 48 h later, males were taken out, females were single-housed, and valproate was applied again until delivery. Respective offspring was killed on postnatal day 0, as well as at the age of 4 and 8 weeks with a single overdose of thiopental. 1 ml blood was collected by cardiac puncture and stored in EDTAcontaining vials. All animals were perfused transcardially with phosphate-buffered saline (PBS). Brain and liver were removed and immediately snap frozen for later analysis. Liver and brain tissue of pups (p0) and 8 week old animals (p56) were used for measurement of folate and homocysteine, DNA-methylation, and histone acetylation. The number of animals included in this biochemical analysis was n = 6 for each group (control, medium dose and high dose), and time point (p0 and p56) resulting in 36 animals totally. Male and female animals were included.
The animals used for brain histology were 4 weeks old (p28). The number of animals included for brain histology was n = 6 for each group (control, medium dose and high dose), resulting in 18 animals totally. Male and female animals were included. After perfusion with a PBS-Puffer, they were also perfused with a fixative containing paraformaldehyde 4%, and picric acid. Brains were removed and postfixated over night, cryoprotected in sucrose 30% over three days, frozen in carbon dioxide snow and stored at À80 C. The experiments were approved by the local Committee for Animal Experimentation. The ARRIVE guidelines and the principles of the Basel declaration including the 3R concept have been considered when planning the experiments.
Stereology
Serial, coronal 30 mm sections were cut and either mounted on slides or collected into a cryoprotectant to be stored at À30 C until further processing.
For neural cell count, slides were Giemsa stained in accordance with the protocol provided by Iniguez et al. [27] .
For astrocyte count slides were glial fibrillary acidic protein (GFAP)-stained. For GFAP-staining, the sections were transferred to tissue restrainers in a 12-well plate and washed three times for 10 min with Histo-tris buffered saline (TBS) (TBS; Triton-X100) and blocked for one hour at room temperature (Histo-TBS, 2.5% goat serum, 2.5% donkey serum). They were incubated over night at 4 C with the primary antibody (guinea pig anti-GFAP, Acris Antibodies GmbH, BP5082 diluted 1:200 in 50% Histo-TBS and 50% blocking solution). After washing, they were incubated 2 h with the secondary antibody (anti-guinea pig CY2, Jackson, 706-255-148, diluted 1:200 in 50% Histo-TBS and 50% blocking solution) and washed again. Afterwards they were mounted with Hydromount (National Diagnostic) and stored protected from light at 4 C.
Stereology measurement
The volume of CA 1/2, and CA3 was estimated on all of the sections using cavalieri estimator methods. Total cell numbers of these hippocampal sections were estimated by the optical fractionator method [28] . Definitions of the hippocampus region boundaries were similar to those illustrated in coronal section by Swanson. The primary data for both the Cavalieri estimator and the optical fractionator were obtained using Stereoinvestigator software (Microbrightfield Inc., Williston, VT, USA) and transferred to other computer programs for further analysis.
Differences within groups were analysed using one-sided ANOVA.
Histone extraction
A histone extraction kit (abcam 113476, Abcam, USA) was used to extract histone proteins from liver and brain tissue. The kit provides a simple and selective method for extracting histone proteins used for a variety of applications, which include histone modifications such as acetylation, methylation and sumoylation. It is also specifically designed to meet the requirements of histone extracts used in histone quantification assays. Briefly, 100 mg of tissue sample was prepared by treating it with 1x Pre-Lysis buffer and subsequent homogenization. After centrifugation the tissue pellet was resuspended in 3 volumes of Lysis buffer and incubated on ice for 30 min. The supernatant was taken and 0.3 volumes of Balance-DTT buffer were added. The protein concentration was quantified by a Bradford Assay and OD reading. BSA was used as a standard. Samples were aliquoted and stored at À80 C until further processing. A more detailed protocol can be found on www. abcam.com.
Western blotting
NuPAGE Novex 4-12% Bis-Tris Gels with 1 mm thickness were used for effective resolution of histone proteins. 10 mg of histone sample was prepared for each lane plus a protein standard. Proteins were detected by the following antibodies: Anti-acetylHistone H3 (Millipore, #06-599, 1:750) and Anti-acetyl-Histone H4 (abcam, #15823, 1:1000). Anti-b-actin (Sigma-Aldrich, #A2228, 1:10000) was used as control antibody in samples of 4-5 weeks and 8 weeks old animals, for tissue samples of pups Anti-y-actin (Sigma-Aldrich, #A8481, 1:10000) was used as the control antibody. Blots were analysed with the software ImageJ.
Measurement of folate fractions
Liver and brain folate vitamers were determined by positiveelectrospray liquid chromatography tandem mass spectrometry (LC-MS/MS) method that allows determination of erythrocyte folate vitamer distribution by accurately measuring both 5-methyltetrahydrofolate (5-methylTHF) and non-methyl folate vitamers.
In short, following cell lysation using Potter-Elvehjem tubes, samples were incubated for 90 min at 37 C to allow deconjugation of the polyglutamate residues using folate depleted plasma. Subsequently, the samples were deproteinized by cooking the samples at 100 C for 20 min. The samples were purified using folate binding protein affinity columns, concentrated by solid phase extraction and evaporation, and subsequently measured by LC-MS/MS [29] . Intra-assay and inter-assay CVs for 5-methyl-THF were 1.2% and 2.8%, respectively. Intra-assay and inter-assay CVs for non-methyl-THF as a group were 1.6% and 1.5%, respectively.
Homocysteine was also measured by LC-MS/MS. Intra-assay CV was <9% [30] .
Determination of global DNA methylation
Global DNA methylation was measured by ultra-high performance liquid chromatography (UHPLC) tandem mass spectrometry with a method adapted from Kok et al. [31] . In short, 2 mg of DNA were hydrolyzed using formic acid. Cytosine (cyt) and 5-methylcytosine (mcyt) were separated using an Ultimate 3000 LC system (Dionex, Sunnyval, CA, USA) and an Acquity BEH Amide The intra-and inter-assay coefficient of variation (CV) for the mcyt/tcyt was 1.7% (n = 9) and 3.5% (n = 9) for calf thymus DNA (mean mCyt/tCyt ratio 6.5%), respectively.
Results
Intrauterine VPA exposure is associated with an increase in volume of the CA3 region and with an increased number of neurons in the CA1/2 and CA3 regions of the hippocampus (Tables 1 and 2 ). Intrauterine VPA exposure is associated with a decrease in the number of astrocytes in CA1/2 and CA3 regions (Table 3) .
Intrauterine VPA exposure is associated with a reduced plasma homocysteine level (Table 4 ). In brain tissue intrauterine VPA exposure leads to an increase in content of 5-methyl-tetrahydrofolate (THF) and a decrease of brain 5-10-methenyl-THF in the high dose VPA group compared with the control group ( Table 4) .
The described changes in hippocampal cell numbers and folate metabolism are only significant when comparing controls with the high dose group of VPA (Tables 1-4). We did not measure global DNA methylation in liver tissue of pups or DNA methylation in four or eight week old animals.
Discussion
This study shows that intrauterine VPA exposure in rats is associated with changes in hippocampal cell numbers and folate metabolism.
We found both, an increase in the volume of hippocampal area CA3, and an increase of hippocampal neurons in the CA1/2 and CA3 regions of the hippocampus in 4 week old animals. We also found a decrease in the number of astrocytes in the CA1/2 and CA3 regions of the hippocampus after intrauterine VPA exposure. It is known, that VPA inhibits proliferation and induces neural differentiation of adult hippocampal neural progenitor cells in vitro and in vivo [32, 33] . This mechanism of action is considered to be "neuroprotective" in different disease models such as stroke [34] , neurodegenerative diseases [35] , or traumatic central nervous system injury [36] [37] [38] . During intrauterine development, Table 4 Folate fractions (in pmol/mg protein) in liver and brain homogenates and homocysteine plasma levels (mmol/l) of pups after valproate exposition in utero in controls (C), the medium dose (MD), and the high dose (HD) group. One-way ANOVA and Bonferroni post hoc tests for comparison between groups. THF = tetrahydrofolate. Italic letters indicate statistically significant results (p < 0.05). however, this action may not be beneficial. Since programmed cell death is an important component of normal brain development, VPA exposure may interfere with normal embryonically regulated apoptotic programs leading to selective cell type overgrowth that could contribute to the defects observed in VPA-exposed offspring. VPA exposure was associated with a decrease in brain 5-10-methenyl-THF levels and an increase in 5-methyl-THF levels. We have no obvious explanation for this finding but like to postulate that VPA inhibits folate metabolism and transport at various sites of its pathway.
The described changes in hippocampal cell numbers and folate metabolism were only significant after high-dose intrauterine VPA exposure. The dose-dependency of the teratogenic effect is a clinically important finding. This in line with results from the pregnancy registry EURAP, which showed that the risk of major congenital malformations increases with VPA dose [1] .
HDAC inhibition was suggested as a likely mechanism of VPA to induce neural differentiation of neural progenitor cells [32] . It is therefore surprising that we were not able to detect histone hyperacetylation in brain or liver tissue of newborn pups. The decreased H3-acetyl ration in liver tissue in the medium dose group cannot be clearly attributed to an effect of VPA exposure, because there was no effect in the high dose group, and because an increased H3-acetylation would be expected after VPA exposure. Speculatively, other mechanisms than HDAC inhibition influence differentiation of progenitor cells. Alternatively, HDAC inhibition exerts a timely limited effect in the offspring of VPA treated mothers, so that the effect of HDAC inhibition on p0 is not detectable any more.
The MRC vitamin study demonstrated that folate supplementation starting before pregnancy was associated with a 72% reduction in the incidence of neural tube defects in women at high risk because of a previously affected pregnancy in a population without women with epilepsy [39] [40] [41] . Folate supplementation is therefore recommended for all women actively planning pregnancy to minimize the risk of neural tube defects. Because valproate is associated with lowered serum folate levels in adult epilepsy patients [12] and because the incidence of neural tube defects after intrauterine VPA exposure is increased it is extrapolated from the studies that women with epilepsy on valproate who are planning to become pregnant should receive folic acid in order to reduce VPS teratogenicity, although this practice has never been proven to be effective [42] . The rat chow used in this study has a high folic acid content (2.88 mg/KG rat chow). This results in a daily intake of 0.14 mg folic acid per kilogram bodyweight in the pregnant female rats. This is considerably more than the daily high dose folic acid intake of up to 4 mg once a day recommended for all women planning pregnancy under valproate, which results in a daily uptake of approximately 0.06 mg folic acid per kilogram bodyweight. It is therefore unlikely that the changes in folic acid metabolism can be alleviated with a high dose folic acid supplementation, although this should be examined with additional experiments using rat chow with low or normal folic acid content.
Folic acid metabolism plays a critical role in the methylation of DNA [18] . In addition, it was already shown that inhibition of intrauterine folate metabolism is associated with DNA hypomethylation, neural tube defects and an altered cellular methylation capacity [8, 14, 20, 21] and that DNA methylation plays an important part in cellular differentiation [43] . We therefore examined global DNA methylation in the brain tissue of pups after intrauterine VPA exposure. Although there was a trend toward DNA hypomethylation, these results did not reach statistical significance. Therefore in our experimental setup utilising a continuous dose of oral VPA exposure no hypomethylation of global DNA could be detected in the offspring. This does however not exclude site-specific alterations of DNA methylation in the offspring, as many studies suggest that the effects of folate deficiency on DNA methylation is gene-specific, and depended on cell type [19] .
Conclusions
This study shows that intrauterine VPA exposure applied via drinking water leads to dose-dependent changes in hippocampal cell numbers in the CA1/2 and the CA3 region and in folic acid metabolism. Surprisingly, acetylation of histones and global DNA methylation were found to be unaltered in brain tissue. Further investigation of mechanisms of VPA teratogenicity and of the benefits of high dose folate supplementation remains necessary.
